Could the Shingles Vaccine Lower Dementia Risk?
Updated: 1 day ago

In 2025, a study from Wales made headlines: older people who had the shingles vaccine appeared less likely to be diagnosed with dementia over the following seven years [1]. Since then, many people have asked whether they should get the vaccine "for their brain". As a neurosurgeon I am not a vaccine specialist, but I read this kind of research closely, and I think the study deserves a careful explanation: what it found, why it is more convincing than most, and what it still cannot tell us.
In brief
A natural experiment in Wales linked the older, live shingles vaccine with a 20% relative reduction in new dementia diagnoses over seven years [1].
A 2024 study of the newer recombinant vaccine and a 2025 study from Australia point in the same direction [2] [8].
None of these studies is a randomised trial, so a protective effect on dementia is not proven.
The NHS offers the vaccine to protect against shingles [3]; if you are eligible, that is a clear reason on its own.
What did the Welsh study find?
In Wales, eligibility for the shingles vaccine was decided by exact date of birth. People born before 2 September 1933 were not eligible, and stayed ineligible for life [1]. That created an unusual situation. People born one week apart, who were almost identical in every other way, had very different chances of being vaccinated: uptake was 0.01% among those just too old to qualify and 47.2% among those just young enough [1].
The researchers compared these two groups. Over seven years of follow-up, the researchers estimated that vaccination reduced the probability of a new dementia diagnosis by 3.5 percentage points, a relative reduction of 20% [1]. They report that the effect was stronger in women than in men [1].
Why is this study taken seriously?
Most research on lifestyle, medicines and dementia is observational. People who choose to be vaccinated may also exercise more, smoke less or see their GP more often, and those differences can create a link that has nothing to do with the vaccine itself. Because the Welsh study used a birth-date cut-off rather than personal choice, the authors argue it gives "causal as opposed to correlational evidence" that is less vulnerable to this kind of bias [1]. A study using the same birth-date approach in Australia found a similar pattern: being eligible for the vaccine lowered the probability of a new dementia diagnosis over 7.4 years by 1.8 percentage points [8].
A second study, published in 2024, used health records from a period when one type of shingles vaccine replaced another. People who received the newer recombinant vaccine had a 17% increase in time lived without a dementia diagnosis, which the authors translated into 164 extra days without a diagnosis among those who were later affected [2]. The recombinant vaccine was also linked with a lower dementia risk than the flu vaccine and the tetanus–diphtheria–whooping cough vaccine [2]. As in the Welsh study, the effect was greater in women [2].
What does this not prove?
It is not a randomised trial. The Welsh design is strong, but it is still a natural experiment. The authors of the 2024 study say their findings could help design a large randomised trial [2], and such a trial is what would settle the question.
We do not know how it works. Neither study establishes a mechanism; the authors of the 2024 study list the mechanisms behind any protection as a question for future research [2].
It used an older vaccine. The Welsh study looked at the live-attenuated shingles vaccine [1]. The UK programme now uses a different, non-live recombinant vaccine, and the live vaccine has not been available for the UK programme since 1 November 2024 [6], so the Welsh result cannot simply be transferred to it. The 2024 study points in the same direction for the recombinant vaccine [2], but it is also observational.
Diagnoses came from records. The Welsh study counted dementia diagnoses recorded in electronic health records [1], and the 2024 study measured time to a recorded diagnosis [2]; neither assessed dementia in every participant.
It says nothing about any one person. A 20% relative reduction in a population [1] does not mean a vaccinated individual will avoid dementia.
Who can get the shingles vaccine on the NHS?
The NHS offers the shingles vaccine to [3]:
people who turned 65 on or after 1 September 2023, from their 65th birthday
everyone aged 70 to 79
people aged 18 or over with a severely weakened immune system, for example some people with blood cancer, HIV, or a recent stem cell or organ transplant
It is given as 2 doses, usually 6 to 12 months apart, or 8 weeks to 6 months apart for people with a severely weakened immune system [3]. Your GP surgery will usually contact you when you become eligible; if you think you are eligible and have not heard, contact your surgery [3].
The NHS offers the vaccine to protect against shingles, not dementia; its vaccine page does not mention dementia [3]. That is the right way to think about it: if you are eligible, the vaccine has a clear purpose already, and a possible brain benefit is an open research question, not a reason in itself.
What can you do for your brain health now?
The most reliable advice has not changed. Many of the risk factors for dementia can be changed, from blood pressure and hearing to physical activity and smoking. I have written about them in my article on 14 changeable risk factors for dementia.
If you or someone close to you is worried about memory, talk to a GP sooner rather than later [4]. Dementia is not a natural part of ageing [4], and early symptoms such as memory loss or difficulty concentrating can appear some time before a diagnosis [4].
When to see a doctor
GP: if you are worried about memory problems or other changes in thinking, sooner rather than later [4]; or if you think you are eligible for the shingles vaccine and have not been contacted [3].
Pharmacist or NHS 111 as soon as possible: if you think you have shingles; antiviral medicine works best if started within 3 days of the rash appearing [5].
Urgent GP appointment or NHS 111: a shingles rash on your eye or nose, or changes to your vision [5].
999: sudden confusion, weakness or speech problems are not a memory problem; they can be a stroke and need emergency help [7].
Frequently asked questions
Does the shingles vaccine prevent dementia?
Not proven. The Welsh study found a 20% relative reduction in new dementia diagnoses over seven years after the older live vaccine [1], but this was a natural experiment, not a randomised trial.
Is the vaccine used in the study the same as the one the NHS uses now?
No. The Welsh study used the live-attenuated vaccine [1]; a 2024 study of the newer recombinant vaccine found a similar direction of effect [2]. The UK programme now uses only the non-live recombinant vaccine [6].
Should I get the shingles vaccine to protect my memory?
If you are eligible, the NHS offers it to protect you from shingles [3]. Any effect on dementia is still being researched.
I am over 80. Can I still have it?
Under current NHS rules, the vaccine is offered until your 80th birthday, and after that only to people with a severely weakened immune system [3].
Written by Kaan Tugberk Ozdemir, MD — Neurosurgeon | Izmir, Türkiye · Last updated: November 2026. This article is for general information and does not replace a consultation.
Sources
Eyting M, Xie M, Michalik F, et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature. 2025;641(8062):438–446.
Taquet M, Dercon Q, Todd JA, Harrison PJ. The recombinant shingles vaccine is associated with lower risk of dementia. Nat Med. 2024;30(10):2777–2781.
NHS. Shingles vaccine. Page last reviewed 1 September 2023 (accessed 10 Nov 2026).
NHS. Symptoms of dementia. Page last reviewed 10 July 2023 (accessed 10 Nov 2026).
NHS. Shingles. Page last reviewed 23 November 2023 (accessed 10 Nov 2026).
UK Health Security Agency. Shingles immunisation programme: information for healthcare practitioners. GOV.UK, last updated 2 September 2025 (accessed 10 Nov 2026).
NHS. Symptoms of a stroke. Page last reviewed 12 September 2024 (accessed 10 Nov 2026).
Pomirchy M, Bommer C, Pradella F, Michalik F, Peters R, Geldsetzer P. Herpes zoster vaccination and dementia occurrence. JAMA. 2025;333(23):2083–2092.



Comments